Jean-Jacques Bienaimé
INDEPENDENT DIRECTORatIncyte· In proxies 2023–2025
Jean-Jacques Bienaimé sits on 4 public boards.
Boards1
- IncyteDirector · 9 yr on the boardIndependentCompensation (Chair), Nominating and Corporate Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- IncytePublic company · 3 yr
- INDEPENDENT DIRECTOR2023 – Present · 3 yrStock in role +47%
- BioMarin Pharmaceutical Inc.Public company
- Director? – PresentNo stock prices for these years
- Immunome, Inc.Public company
- Director? – PresentNo stock prices for these years
- Keros Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?